Hamamatsu Photonics of Japan and Massachusetts-based Vizgen have announced a strategic partnership intended to speed up research laboratory workflows. The collaboration will in particular aim to ...

Direct immunofluorescence biopsy may be a useful tool in the diagnosis of pediatric patients with potential immune-mediated skin disorders.

The collaboration will in particular aim to integrate Hamamatsu's MoxiePlex multiplex immunofluorescence (mIF) imaging system with Vizgen's pathology-grade reagent and assay portfolio. The goal is to ...